{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:58:55Z","timestamp":1760821135388,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12029-020-00411-1","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:03:42Z","timestamp":1589191422000},"page":"515-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeted Therapies in Trial for Non-Resectable Gallbladder Cancer"],"prefix":"10.1007","volume":"52","author":[{"given":"Ali A.","family":"Nasrallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7537-9033","authenticated-orcid":false,"given":"Hussein H.","family":"Khachfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza A.","family":"Salhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad Y.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Fares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"doi-asserted-by":"publisher","unstructured":"Khachfe HH, Salhab HA, Fares MY, Khachfe HM. Probing the colorectal cancer incidence in Lebanon: an 11-year epidemiological study. J Gastrointest Cancer. 2019. https:\/\/doi.org\/10.1007\/s12029-019-00284-z.","key":"411_CR1","DOI":"10.1007\/s12029-019-00284-z"},{"issue":"8","key":"411_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3390\/medicina55080463","volume":"55","author":"MY Fares","year":"2019","unstructured":"Fares MY, Salhab HA, Khachfe HH, Khachfe HM. Breast cancer epidemiology among Lebanese women: an 11-year analysis. Medicina (Kaunas). 2019;55(8):463. https:\/\/doi.org\/10.3390\/medicina55080463.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"411_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/medicina55060217","volume":"55","author":"HA Salhab","year":"2019","unstructured":"Salhab HA, Fares MY, Khachfe HH, Khachfe HM. Epidemiological study of lung cancer incidence in Lebanon. Medicina (Kaunas). 2019;55(6):217. https:\/\/doi.org\/10.3390\/medicina55060217.","journal-title":"Medicina (Kaunas)"},{"doi-asserted-by":"publisher","unstructured":"Khachfe HH, Rahal Z, Sammouri J, Kheil MH, Baydoun H, Chatila D, et al. Cancer in Lebanon: a review of incidence rates from 2008\u20132015 and projections till 2025. South Asian Journal of Cancer. 2020. https:\/\/doi.org\/10.4103\/sajc.sajc_301_19. In Press.","key":"411_CR4","DOI":"10.4103\/sajc.sajc_301_19"},{"issue":"6","key":"411_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Mu\u00f1oz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364. https:\/\/doi.org\/10.3322\/canjclin.51.6.349.","journal-title":"CA Cancer J Clin"},{"issue":"15","key":"411_CR6","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/jnci\/89.15.1132","volume":"89","author":"WA Zatonski","year":"1997","unstructured":"Zatonski WA, Lowenfels AB, Boyle P, Maisonneuve P, Bueno de Mesquita HB, Ghadirian P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer. J Natl Cancer Inst. 1997;89(15):1132\u20138. https:\/\/doi.org\/10.1093\/jnci\/89.15.1132.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"411_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485\u20139. https:\/\/doi.org\/10.1002\/jso.21141.","journal-title":"J Surg Oncol"},{"issue":"5","key":"411_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archsurg.2009.46","volume":"144","author":"IT Konstantinidis","year":"2009","unstructured":"Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009;144(5):441\u20137. https:\/\/doi.org\/10.1001\/archsurg.2009.46.","journal-title":"Arch Surg"},{"issue":"2","key":"411_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1148\/radiographics.21.2.g01mr16295","volume":"21","author":"AD Levy","year":"2001","unstructured":"Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics. 2001;21(2):295\u2013555. https:\/\/doi.org\/10.1148\/radiographics.21.2.g01mr16295.","journal-title":"Radiographics"},{"issue":"6","key":"411_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1572-0241.2000.02070.x","volume":"95","author":"S Sheth","year":"2000","unstructured":"Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol. 2000;95(6):1402\u201310. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.02070.x.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"411_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15(2):168\u201381. https:\/\/doi.org\/10.1634\/theoncologist.2009-0302.","journal-title":"Oncologist"},{"issue":"10","key":"411_CR12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.7326\/l14-5022","volume":"161","author":"JE Becker","year":"2014","unstructured":"Becker JE, Ross JS. Reporting discrepancies between the clinicaltrials.gov results database and peer-reviewed publications. Ann Intern Med. 2014;161(10):760. https:\/\/doi.org\/10.7326\/l14-5022.","journal-title":"Ann Intern Med"},{"issue":"6","key":"411_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/02656736.2015.1040471","volume":"31","author":"N Cihoric","year":"2015","unstructured":"Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia. 2015;31(6):609\u201314. https:\/\/doi.org\/10.3109\/02656736.2015.1040471.","journal-title":"Int J Hyperthermia"},{"issue":"17","key":"411_CR14","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1001\/jama.2012.3424","volume":"307","author":"RM Califf","year":"2012","unstructured":"Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. Jama. 2012;307(17):1838\u201347. https:\/\/doi.org\/10.1001\/jama.2012.3424.","journal-title":"Jama"},{"issue":"5","key":"411_CR15","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/nop\/npz003","volume":"6","author":"J Fares","year":"2019","unstructured":"Fares J, Kanojia D, Cordero A, Rashidi A, Miska J, Schwartz CW, et al. Current state of clinical trials in breast cancer brain metastases. Neuro-Oncology Practice. 2019;6(5):392\u2013401. https:\/\/doi.org\/10.1093\/nop\/npz003.","journal-title":"Neuro-Oncology Practice"},{"issue":"1","key":"411_CR16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S1470-2045(09)70333-X","volume":"11","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H, et al. Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol. 2010;11(1):48\u201354. https:\/\/doi.org\/10.1016\/S1470-2045(09)70333-X.","journal-title":"Lancet Oncol"},{"issue":"14","key":"411_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"issue":"24","key":"411_CR18","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","volume":"33","author":"E Ben-Josef","year":"2015","unstructured":"Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33(24):2617\u201322. https:\/\/doi.org\/10.1200\/JCO.2014.60.2219.","journal-title":"J Clin Oncol"},{"issue":"4","key":"411_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2214\/AJR.14.13223","volume":"204","author":"DV Sahani","year":"2015","unstructured":"Sahani DV, Hayano K, Galluzzo A, Zhu AX. Measuring treatment response to systemic therapy and predicting outcome in biliary tract cancer: comparing tumor size, volume, density, and metabolism. AJR Am J Roentgenol. 2015;204(4):776\u201381. https:\/\/doi.org\/10.2214\/AJR.14.13223.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"411_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"411_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4103\/1947-2714.101979","volume":"4","author":"A Andr\u00e9n-Sandberg","year":"2012","unstructured":"Andr\u00e9n-Sandberg A. Molecular biology of gallbladder cancer: potential clinical implications. N Am J Med Sci. 2012;4(10):435\u201341. https:\/\/doi.org\/10.4103\/1947-2714.101979.","journal-title":"N Am J Med Sci"},{"key":"411_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;11:156\u201364. https:\/\/doi.org\/10.1016\/j.conctc.2018.08.001.","journal-title":"Contemp Clin Trials Commun"},{"key":"411_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1196\/annals.1425.030","volume":"1136","author":"D Kammen","year":"2008","unstructured":"Kammen D, Kirubi C. Poverty, energy, and resource use in developing countries. Ann N Y Acad Sci. 2008;1136:348\u201357. https:\/\/doi.org\/10.1196\/annals.1425.030.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"411_CR24","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/1097-0142(19951115)76:10<1747::aid-cncr2820761011>3.0.co;2-l","volume":"76","author":"BL Strom","year":"1995","unstructured":"Strom BL, Soloway RD, Rios-Dalenz JL, Rodriguez-Martinez HA, West SL, Kinman JL, et al. Risk factors for gallbladder cancer. An international collaborative case-control study. Cancer. 1995;76(10):1747\u201356. https:\/\/doi.org\/10.1002\/1097-0142(19951115)76:10<1747::aid-cncr2820761011>3.0.co;2-l.","journal-title":"Cancer"},{"issue":"2","key":"411_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102. https:\/\/doi.org\/10.5114\/ceh.2019.85166.","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"411_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1056\/NEJMra1510062","volume":"377","author":"J Woodcock","year":"2017","unstructured":"Woodcock J, LaVange LM. Master protocols to study multiple therapies, multiple diseases, or both. N Engl J Med. 2017;377(1):62\u201370. https:\/\/doi.org\/10.1056\/NEJMra1510062.","journal-title":"N Engl J Med"},{"key":"411_CR27","doi-asserted-by":"publisher","first-page":"f6104","DOI":"10.1136\/bmj.f6104","volume":"347","author":"CW Jones","year":"2013","unstructured":"Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013;347:f6104. https:\/\/doi.org\/10.1136\/bmj.f6104.","journal-title":"BMJ"},{"issue":"2","key":"411_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clcc.2013.12.005","volume":"13","author":"CS Denlinger","year":"2014","unstructured":"Denlinger CS, Meropol NJ, Li T, Lewis NL, Engstrom PF, Weiner LM, et al. A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers. Clin Colorectal Cancer. 2014;13(2):81\u20136. https:\/\/doi.org\/10.1016\/j.clcc.2013.12.005.","journal-title":"Clin Colorectal Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00411-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00411-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T13:20:01Z","timestamp":1628601601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00411-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00411-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"11 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}